Log in to save to my catalogue

CD206+ macrophages are relevant non-invasive imaging biomarkers and therapeutic targets in experimen...

CD206+ macrophages are relevant non-invasive imaging biomarkers and therapeutic targets in experimen...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11672011

CD206+ macrophages are relevant non-invasive imaging biomarkers and therapeutic targets in experimental lung fibrosis

About this item

Full title

CD206+ macrophages are relevant non-invasive imaging biomarkers and therapeutic targets in experimental lung fibrosis

Publisher

England: BMJ Publishing Group Ltd and British Thoracic Society

Journal title

Thorax, 2024-12, Vol.79 (12), p.1124-1135

Language

English

Formats

Publication information

Publisher

England: BMJ Publishing Group Ltd and British Thoracic Society

More information

Scope and Contents

Contents

BackgroundInterstitial lung diseases (ILDs) include a large number of diseases associated with progressive pulmonary fibrosis (PPF), including idiopathic pulmonary fibrosis (IPF). Despite the rarity of each of the fibrotic ILDs individually, they cumulatively affect a considerable number of patients. PPF is characterised by an excessive collagen de...

Alternative Titles

Full title

CD206+ macrophages are relevant non-invasive imaging biomarkers and therapeutic targets in experimental lung fibrosis

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11672011

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11672011

Other Identifiers

ISSN

0040-6376,1468-3296

E-ISSN

1468-3296

DOI

10.1136/thorax-2023-221168

How to access this item